TEI Biosciences Revenue and Competitors

Every day, in operating rooms around the world, surgeons are faced with challenging repairs and reconstructions of soft tissues in cancer, trauma, diabetic, burn, and sports medicine patients. For their most challenging repairs, surgeons choose TEI Biosciences’ novel biologic products for superior clinical outcomes. More than a quarter of a million patients, worldwide, have benefitted from TEI’s innovations in biomedicine since the launch of TEI’s first product, a regeneration matrix to repair the dura mater during neurosurgical procedures. Founded in 1993, with technology out of the Massachusetts Institute of Technology, TEI is a Boston area based, leading biomedical company, applying its expertise in regenerative medicine to develop and commercialize novel biologic devices for a broad spectrum of soft tissue repair, reinforcement, and reconstruction applications